In our study, no significant difference in Tg levels was observed between the metastatic and nonmetastatic groups, indicating that Tg is not an independent predictor; therefore, the authors suggest that whether serum Tg can be used as a routine preoperative measurement to assess the aggressiveness of thyroid nodules needs to be confirmed by further studies. The gene discussed is TG; the disease is thyroid nodule.